Less: accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Award Timing Predetermined Award Timing Predetermined [Flag] Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] 2024 Term Loan Two Thousand Twenty Four Loan and Security Agreement [Member] Two thousand twenty four loan and security agreement. Accounting Standards Updates New Accounting Pronouncements, Policy [Policy Text Block] FAIR VALUE MEASUREMENTS Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block] Research and development tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount License License [Member] Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Employee-related costs (including share-based compensation) Employee Related Costs, General And Adminstrative Expense Employee Related Costs, General And Adminstrative Expense Ownership percentage change in outstanding common stock period (in years) Ownership Percentage Change In Outstanding Common Stock Period Ownership percentage change in outstanding common stock period. Loss (gain) on changes in other fair value adjustments Fair Value, Option, Changes in Fair Value, Gain (Loss) ESPP Employee Stock Purchase Plan [Member] Employee Stock Purchase Plan Restricted stock units vested (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Issuance of common stock under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Provision to return Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount $189.30 - $293.70 Price Range Nine [Member] Price range nine. Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk, percentage (as a percent) Concentration Risk, Percentage Share-based compensation Share-Based Payment Arrangement, Noncash Expense Employee Stock Option Share-Based Payment Arrangement, Option [Member] Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Note receivable—net Carrying value of note receivable Financing Receivable, after Allowance for Credit Loss Grantee Status [Domain] Grantee Status [Domain] % of Pre-Tax Loss Effective Income Tax Rate Reconciliation, Percent [Abstract] Impairment charges Impairment charges Impairment charges included in continuing operations Asset Impairment Charges Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Schedule of Property, Equipment, and Software Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Proceeds from issuance of common stock, net of issuance cost (in shares) Stock Issued During Period, Shares, New Issues Concentrations of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Adjustments to reconcile net loss to net cash used in operating activities: Cash Provided by (Used in) Discontinued Operation [Abstract] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Other Effective Income Tax Rate Reconciliation, Tax Exempt income, Other, Percent Effective Income Tax Rate Reconciliation, Tax Exempt income, Other, Percent State State and Local Jurisdiction [Member] Cover Cover [Abstract] Money market funds Cash and Cash Equivalents, Fair Value Disclosure DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Maximum Maximum [Member] Currently exercisable, weighted-average exercise price (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Intangible assets, net Finite-Lived Intangible Assets, Net Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Entity Shell Company Entity Shell Company Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Schedule of Cash Income Taxes Paid (Received) Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Exercise Price Range Exercise Price Range [Axis] (Loss) income from continuing operations (Loss) income from continuing operations (Loss) income from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Lease liabilities Operating Lease, Liability, Current Nontaxable or nondeductible items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract] Novartis Pharma AG Novartis Pharma A G [Member] Novartis Pharma A.G. Software Software and Software Development Costs [Member] Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Basic (loss) income from continuing operations (in USD per shares) Income (Loss) from Continuing Operations, Per Basic Share Furniture and fixtures Furniture and Fixtures [Member] Award Type Award Type [Axis] Gain on change in fair value of warrant liability Gain (Loss) on Change in Fair Value of Warrant Liability Gain (Loss) on Change in Fair Value of Warrant Liability Deferred revenue Contract with Customer, Liability, Noncurrent Collaboration and License Agreements [Line items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Investment, Name [Domain] Investment, Name [Domain] Share-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Trading Symbol Trading Symbol 2029 Lessee, Operating Lease, Liability, to be Paid, Year Four Changes in valuation allowances Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Uncertain tax position Liability for Uncertainty in Income Taxes, Current Entity Address, City or Town Entity Address, City or Town Short-Term Debt, Type [Domain] Short-Term Debt, Type [Domain] Asset Impairment Charges [Abstract] Asset Impairment Charges [Abstract] INTANGIBLE ASSETS Intangible Assets Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location Statement of Income Location, Balance [Domain] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Other Adjustments Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount [Abstract] Number of shares available for issuance (in shares) Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Issuance Share based compensation arrangement by share based payment award number of shares available for issuance. Options outstanding (in shares) Outstanding option shares, beginning balance (in shares) Outstanding option shares, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Repayment of revolving credit facility Repayments of Lines of Credit Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Restricted cash Restricted Cash and Cash Equivalent Lease liability Deferred Tax Assets Lease Liability Deferred tax assets lease liability Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Table] $12.59 - $46.20 Price Range One [Member] Price range one. Investment in iECURE Investment In I E C U R E [Member] Investment in iECURE member. Weighted- average remaining life (in years) Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Increase (decrease) in valuation allowance of net deferred tax assets Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Contribution carryforwards Deferred Tax Assets, Charitable Contribution Carryforwards Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Guarantee liabilities Guarantor Obligations, Current Carrying Value Orphan Drug Tax Credit Carry forward Orphan Drug Tax Credit Carryforward [Member] Orphan drug tax credit carryforward. 2021 Appropriations Act Two Thousand Twenty One Appropriations Act [Member] 2021 Appropriations Act. Diluted gain (loss) from discontinued operations (in USD per shares) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Effective interest rate (as percent) Debt Instrument, Interest Rate, Effective Percentage RSU Awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Effective tax rate Income Tax Expense (Benefit) Basis point added to the prime rate (as percent) Debt Instrument, Basis Spread on Variable Rate TG License TG License [Member] TG license. Balance December 31, 2024 Balance December 31, 2025 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Proceeds from issuance of common stock and warrants through underwritten offering, net of issuance costs (in shares) Stock And Warrants Issued During Period Through Underwritten Offering, Net Of Issuance Cost, Shares Stock and warrants issued during period through underwritten offering, net of issuance cost, shares. Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Axis] Total property, equipment and software Property, Plant and Equipment, Gross Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] Guarantor Obligation [Table] Guarantor Obligation [Table] Amortization of right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Federal Income Tax Paid, Federal, after Refund Received All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Noncurrent deferred tax liability: Deferred Tax Liabilities, Gross [Abstract] Unvested, beginning balance (in shares) Unvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Proceeds from issuance of common stock through ATM facility, net of issuance cost (in shares) Stock Issued During Period Through A T M Facility, Net Of Issuance Cost, Shares Stock issued during period through atm facility, net of issuance cost shares. Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Equity Method Investments and Joint Ventures [Abstract] Assets sold Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales Property plant and equipment useful life (in years) Property, Plant and Equipment, Useful Life Preferred stock, par value (in USD per shares) Preferred Stock, Par or Stated Value Per Share Schedule of Stock Options Valuation Assumptions Using a Black-Scholes Option Pricing Model Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Equity Components Equity Components [Axis] Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Sublease income Sublease Income Imugene marketable securities Convertible Debt [Member] Purchases of intangibles assets Payments To Purchase Intangible Assets Payments To Purchase Intangible Assets Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Impaired Long-Lived Assets Held and Used [Line Items] Impaired Long-Lived Assets Held and Used [Line Items] Number of reportable segments Number of Reportable Segments Loan payable Loans Payable Consideration Received [Axis] Consideration Received [Axis] Consideration Received Entity Address, State or Province Entity Address, State or Province Total current liabilities Liabilities, Current Individual: Individual [Axis] Defined contribution plan, company made contribution to the retirement plan Defined Contribution Plan, Cost Imugene Imugene Marketable Securities Imugene [Member] Imugene. Income Tax Authority Income Tax Jurisdiction [Domain] Document Annual Report Document Annual Report Research and development Research and Development Expense [Member] $305.10 - $480.00 Price Range Five [Member] Price range five. Proceeds from offering of common stock to collaboration partners and licensees Proceeds from Noncontrolling Interests Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Capitalized R&D costs Deferred Tax Asset, In-Process Research and Development Entity Interactive Data Current Entity Interactive Data Current Percentage of premium over the volume-weighted-average-price of the company’s common stock (as a percent) Percentage Of Premium Over Volume Weighted Average Price Of Company's Common Stock Percentage of premium over the volume-weighted-average-price of the company’s common stock. Fair Value Warrant Liability [Roll Forward] Fair Value Warrant Liability [Roll Forward] Fair Value Warrant Liability Deferred revenue Deferred Tax Assets, Deferred Income Revenue Recognition for Contracts with Customers Revenue from Contract with Customer [Policy Text Block] Equity compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Federal contribution carryforwards Federal Contribution Carryforwards Federal contribution carryforwards. Description Of Business And Summary Of Significant Accounting Policies [Line Items] Description Of Business And Summary Of Significant Accounting Policies [Line Items] Description of business and summary of significant accounting policies. Number of trading days prior to agreement to determine price per share Stock Issued, Price Per Share, Number Of Trading Days Prior To Agreement Stock Issued, Price Per Share, Number Of Trading Days Prior To Agreement Other assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Direct research and development expenses by product candidate: Research and Development Expense [Abstract] Summary of Stock Options Granted under the Stock Option Plans are Vested or Expected to Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Deferred revenue Contract with Customer, Liability, Current Nontaxable or nondeductible items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract] Operating Leases Lessee, Operating Lease, Description [Abstract] Prevail Prevail [Member] Prevail. Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Valuation Allowance by Deferred Tax Asset [Axis] Valuation Allowance by Deferred Tax Asset [Axis] US federal statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Intangible assets amortization expense for 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Three Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Noncurrent deferred tax assets: Deferred Tax Assets, Net [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Research and development Total research and development expenses Research and Development Expense Summary of Stock Options Outstanding under the Stock Option Plans Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] Final payment fee paid Final Payment Fee Final payment fee. Exercise price, lower limit (in USD per shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Property Lease Guarantee Property Lease Guarantee [Member] Net operating loss carryforwards Operating Loss Carryforwards Changes in unrecognized tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Schedule of Estimated Fair Value of Warrants Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name Counterparty Name [Domain] WARRANTS Warrants [Text Block] Warrants. 2027 Lessee, Operating Lease, Liability, to be Paid, Year Two Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Non-PEO NEO Non-PEO NEO [Member] Issuance of common stock under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Interest income Interest Income, Other Elo Elo [Member] Elo. Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Early termination fee Payment for Debt Extinguishment or Debt Prepayment Cost All Award Types Award Type [Domain] 2026 Lessee, Operating Lease, Liability, to be Paid, Year One Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Licensing fees and other research and development costs Licensing Fees And Other Research And Development Costs Licensing Fees And Other Research And Development Costs Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Debt Instrument, Name Debt Instrument, Name [Domain] Estimated dividend yield (as percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Revenue recorded included in deferred revenue Revenue recognized Contract with Customer, Liability, Revenue Recognized MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] PBGENE-3243 external development costs PBGENE - 3243 Program [Member] PBGENE 3243 programs. Banc of California Revolving Line Banc of California Revolving Line [Member] Banc of California Revolving Line Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Amount [Abstract] Financial Instruments [Domain] Financial Instruments [Domain] Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases Operating lease liabilities arising from obtaining right-of-use assets Operating Lease Liability Obtained In Exchange for Right-of-Use Asset Operating Lease Liability Obtained In Exchange for Right-of-Use Asset Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Other Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Other Adjustments Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent [Abstract] Minimum Minimum [Member] Company Selected Measure Name Company Selected Measure Name DEBT Debt Disclosure [Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Operating cash flows used for operating leases Operating Lease, Payments Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Discontinued Operations Discontinued Operations [Member] External development costs (credits) External Development Costs (Credits) External development costs. Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Proceeds from issuance of common stock and warrants through underwritten offering, net of issuance costs Stock And Warrants Issued During Period Value Through Underwritten Offering, Net Of Issuance Cost Stock and warrants issued during period value through underwritten offering, net of issuance cost. COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Diluted (in shares) Diluted weighted-average common shares (in shares) Weighted Average Number of Shares Outstanding, Diluted Segment Reporting Segment Reporting, Policy [Policy Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Small Business Entity Small Business Accrued research and development expenses Disposal Group Including Discontinued Operation Accrued Research and Development Expenses Current Disposal group including discontinued operation accrued research and development expenses current. Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Other operating expenses and all other costs Other Cost and Expense, Operating Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Operating Segment Operating Segment [Member] Operating Segment Underlying Securities Award Underlying Securities Amount Equity Component Equity Component [Domain] Document Period End Date Document Period End Date Expiration of patents, period Period Of Expiration Of Patents Period Of Expiration Of Patents INCOME TAXES Income Tax Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Short-term lease cost Short-Term Lease, Cost Currently exercisable, weighted-average remaining contractual life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Lease liabilities Increase (Decrease) in Operating Lease Liability Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Non-cash interest expense Amortization of Debt Discount (Premium) Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] RSU outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number EARNINGS PER SHARE Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name IMPAIRMENT CHARGES Asset Impairment Charges [Text Block] Product and Service [Axis] Product and Service [Axis] Furniture and fixtures and office equipment Office equipment Office Equipment [Member] Variable lease cost Variable Lease, Cost Revenue Revenue from Contract with Customer, Excluding Assessed Tax Total current assets Assets, Current Statistical Measurement Statistical Measurement [Axis] Other Effective Income Tax Rate Reconciliation, Tax Exempt Income, Other, Amount Effective Income Tax Rate Reconciliation, Tax Exempt Income, Other, Amount Contract liabilities Loss Contingency Accrual Gain on dilution under equity method Equity Method Investment, Realized Gain (Loss) on Disposal Forfeited/canceled (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Financing receivable, accrued interest, percentage (as a percent) Financing Receivable, Interest Rate, Percentage Financing Receivable, Interest Rate, Percentage Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Disposal Group Name [Axis] Disposal Group Name [Axis] Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Marketable securities Marketable Securities, Current Current liabilities: Liabilities, Current [Abstract] Guarantor Obligations, Nature [Domain] Guarantor Obligations, Nature [Domain] Total operating expenses Total operating expenses Operating Expenses Level 1 Fair Value, Inputs, Level 1 [Member] Allowed annual percentage increase in shares authorized as percentage of outstanding shares of common stock (as percent) Allowed Annual Percentage Increase In Shares Authorized As Percentage Of Outstanding Shares Of Common Stock Allowed annual percentage increase in shares authorized as percentage of outstanding shares of common stock. Loss on disposal of assets Gain (Loss) on Disposition of Assets Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Other liabilities and other current liabilities Increase Decrease In Accrued Other Expenses And Other Current Liabilities Increase decrease in accrued other expenses and other current liabilities. Diluted (in USD per shares) Diluted net (loss) income per share (in USD per shares) Earnings Per Share, Diluted Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Supplemental disclosures of noncash financing and investing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Assets held for sale Long-Lived Asset, Held-for-Sale, Fair Value Disclosure 2019 ESPP Two Thousand Nineteen Employee Stock Purchase Plan [Member] Two thousand nineteen employee stock purchase plan. Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Proceeds from sale of equipment Proceeds from Sale of Machinery and Equipment State and local Income Tax Paid, State and Local, after Refund Received Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Auditor Location Auditor Location Prepaid expenses Increase (Decrease) in Prepaid Expense ELO TRANSACTION Equity Method Investments and Joint Ventures Disclosure [Text Block] Impairment charges included in held for sale Disposal Group, Including Discontinued Operations, Asset Impairment Charges Disposal Group, Including Discontinued Operations, Asset Impairment Charges Consulting and professional services Consulting And Professional Services Consulting and professional services. Description Of Business And Summary Of Significant Accounting Policies [Table] Description Of Business And Summary Of Significant Accounting Policies [Table] Description of business and summary of significant accounting policies. Comprehensive (Loss) Income Comprehensive Income, Policy [Policy Text Block] Federal Domestic Tax Jurisdiction [Member] Marketable securities Increase (Decrease) in Marketable Securities, Restricted Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Platform development and early-stage research expenses: Platform development and early-stage research expenses [Abstract] Platform development and early-stage research expenses. Tax Credit Carryforward Tax Credit Carryforward [Axis] Income taxes, net of amounts refunded Income Taxes Paid, Net Other Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Intangible assets amortization expense for 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Two Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Granted (in USD per shares) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Accrued compensation Employee-related Liabilities, Current PROPERTY, EQUIPMENT AND SOFTWARE AND ASSETS HELD FOR SALE Property, Plant and Equipment Disclosure [Text Block] Total lease payments Lessee, Operating Lease, Liability, to be Paid Expiration Date Trading Arrangement Expiration Date Additional milestone Revenue, Remaining Performance Obligation, Variable Consideration, Additional Milestone, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Additional Milestone, Amount $193.50 - $293.70 Price Range Four [Member] Price range four. Intangible assets amortization expense for 2030 Finite-Lived Intangible Asset, Expected Amortization, Year Five Property, equipment, and software—net Property, equipment and software - net Property, Plant and Equipment, Net Change in warrant liability Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Change In Warrant Liability, Percent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Change In Warrant Liability, Percent Expected to be exercisable, weighted-average remaining contractual life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] US federal statutory tax rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Executive Category: Executive Category [Axis] Equity compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent State and local income taxes, net of federal income taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Property, equipment and software additions included in accounts payable, accrued expenses and other current liabilities Noncash or Part Noncash Acquisition, Fixed Assets Acquired Current Fiscal Year End Date Current Fiscal Year End Date Inducement Award Plan Inducement Award Plan [Member] Inducement award plan member. Promissory Note Promissory Note [Member] Promissory Note. Expected term of options (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Cell Therapy Operations Cell Therapy Operations [Member] Cell Therapy Operations. Weighted-Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Remaining shares available to be granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Intangible asset additions included in accounts payable and accrued expenses and other current liabilities Noncash or Part Noncash Acquisition, Intangible Assets Acquired Warrant liability Derivative Liability COLLABORATION AND LICENSE AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Cash Cash [Member] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] PBGENE-HBV external development costs PBGENE - Hepatitis B Virus [Member] Potential treatment of chronic hepatitis B virus. Effect of changes in tax laws or rates enacted in the current period Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Schedule of Assets and Liabilities Measured on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Unrecognized tax benefits Unrecognized Tax Benefits Borrowings from term loan debt facility, net of issuance costs paid to lender Proceeds from Debt, Net of Issuance Costs Antidilutive common share equivalents (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Financial Guarantee Financial Guarantee [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Measure: Measure [Axis] Income Tax Disclosure [Table] Income Tax Disclosure [Table] Income tax disclosure. Summary of Warrant Liability Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Disposal Group Classification Disposal Group Classification [Domain] Payment Tranche [Domain] Payment Tranche [Domain] Payment Tranche [Domain] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Weighted-average risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Entity Tax Identification Number Entity Tax Identification Number Grantee Status [Axis] Grantee Status [Axis] Other assets and other current assets Increase Decrease In Other Assets And Other Current Assets Increase decrease in other assets and other current assets. Weighted-average exercise price outstanding at beginning balance (in USD per shares) Weighted-average exercise price outstanding at ending balance (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Common stock, shares issued (in shares) Common Stock, Shares, Issued Weighted average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Entity Public Float Entity Public Float Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Security Exchange Name Security Exchange Name Foreign Income Tax Paid, Foreign, after Refund Received Defined contribution plan, administrative fees Defined Contribution Plan, Administrative Expense Principal amount Line of Credit Facility, Maximum Borrowing Capacity Operating expenses Operating Expenses [Abstract] Prepaid expenses Prepaid Expense, Current Other current liabilities Other Liabilities, Current Asset Class Asset Class [Domain] Loss from changes in fair value included in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Research and Development Research Tax Credit Carryforward [Member] Common Stock Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Dilutive impact of share-based awards (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Payment Tranche [Axis] Payment Tranche [Axis] Payment Tranche Guarantor Obligations [Line Items] Guarantor Obligations [Line Items] Statistical Measurement Statistical Measurement [Domain] Weighted-average shares of common stock outstanding Earnings Per Share, Diluted, Other Disclosure [Abstract] November 2025 Public Offering November 2025 Public Offering [Member] November 2025 Public Offering Asset Class Asset Class [Axis] Reverse Stock Split Reverse Stock Split [Policy Text Block] Reverse stock split. Loss from equity method investment Loss from equity method investment Income (Loss) from Equity Method Investments Basic net (loss) income per share: Earnings Per Share, Basic [Abstract] Facility-related costs, laboratory equipment, and maintenance Facility Related Costs, Laboratory Equipment, And Maintenance Facility Related Costs, Laboratory Equipment, And Maintenance Accounts payable Increase (Decrease) in Accounts Payable Consolidated Financial Statements Presented as Discontinued Operations Disposal Groups, Including Discontinued Operations [Table Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants outstanding (in shares) Class of Warrant or Right, Outstanding Basic (in USD per shares) Basic net (loss) income per share (in USD per shares) Earnings Per Share, Basic Liabilities: Liabilities, Fair Value Disclosure [Abstract] Number of shares available to be issued (in shares) Common Stock, Capital Shares Reserved for Future Issuance Changes in unrecognized tax benefits Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Summary of Significant Research and Development and General and Administrative Expense to CODM Schedule of Segment Reporting Information, by Segment [Table Text Block] Measurement Input Type [Domain] Measurement Input Type [Domain] Impaired Long-Lived Asset, Held and Used [Table] Impaired Long-Lived Asset, Held and Used [Table] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Cash received from sale of business Proceeds from Sale of Productive Assets Research and Development Research and Development Expense, Policy [Policy Text Block] Share-based compensation expense Share-Based Payment Arrangement, Expense Borrowings Line of Credit Facility, Maximum Amount Outstanding During Period Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Current assets: Assets, Current [Abstract] Total liabilities and stockholders’ equity Liabilities and Equity Outstanding Option Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Payment Tranche Two Payment Tranche Two [Member] Payment Tranche Two Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Other income (expense): Other Nonoperating Income (Expense) [Abstract] Other assets Deferred Tax Assets, Other 2015 Plan Two Thousand Fifteen Stock Incentive Plan [Member] Two thousand fifteen stock incentive plan. Convertible note receivable Increase (Decrease) in Notes Receivables License cost Finite-Lived License Agreements, Gross General and administrative General and Administrative Expense [Member] Equity Method Investment [Table] Equity Method Investment [Table] Schedule of Future Lease Payments under Non-Cancelable Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Treasury Stock Treasury Stock, Common [Member] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Total operating lease liabilities Operating Lease, Liability Final payment fee Financial Liabilities Fair Value Disclosure Number of options exercisable (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Other noncurrent liabilities Other Liabilities, Noncurrent Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Exercise price, upper limit (in USD per shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount 2028 Lessee, Operating Lease, Liability, to be Paid, Year Three Measurement Input Type [Axis] Measurement Input Type [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Name Measure Name Total deferred tax liabilities, noncurrent Deferred Income Tax Liabilities, Net Gain from discontinued operations Gain (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current [Abstract] Legal Entity [Axis] Legal Entity [Axis] Proceeds from issuance of common stock through ATM facility, net of issuance cost Stock Issued During Period, Value Through A T M Facility, Net Of Issuance Cost Stock issued during period value through atm facility, net of issuance cost. Total assets Assets Ownership percentage in outstanding common stock (as a percent) Ownership Percentage Change Of Outstanding Common Stock Ownership percentage change of outstanding common stock. Intangible assets amortization expense for 2026 Finite-Lived Intangible Asset, Expected Amortization, Year One Vested (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Income Taxes Income Tax, Policy [Policy Text Block] $10.33 - $46.50 Price Range Six [Member] Price range six. Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Receivable Type [Axis] Receivable Type [Axis] DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Research and development tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Concentration Risk Type [Axis] Concentration Risk Type [Axis] Assets: Assets, Fair Value Disclosure [Abstract] Intangible assets amortization expense for 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Four Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Operating right-of-use assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Lease Cost Lease, Cost [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Document Financial Statement Error Correction [Flag] Document Financial Statement Error Correction [Flag] State and local income taxes, net of federal income taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Equity method investment Equity Method Investments Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Discontinued Operations Discontinued Operations, Policy [Policy Text Block] Change in fair value of warrant liability Change in fair value of warrant liability Fair Value Adjustment of Warrants Schedule of Components of Loss (Income) Before Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Plan Name Plan Name [Axis] Property, Equipment and Software Property, Plant and Equipment, Policy [Policy Text Block] PEO PEO [Member] Total pre-tax book income (loss) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in valuation allowances Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Weighted-average expected stock price volatility Measurement Input, Share Price [Member] Weighted-average expected stock price volatility (as percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Proceeds from issuance of common stock to collaboration partners and licensees (in shares) Stock Issued During Period Collaboration Partners And Licenses Shares Stock issued during period collaboration partners and licenses shares. Accumulated Deficit Retained Earnings [Member] Income Tax Authority Income Tax Jurisdiction [Axis] Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash, cash equivalents, and restricted cash—beginning of period Cash, cash equivalents, and restricted cash —end of period Total of cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Weighted-average fair value per option Measurement Input, Weighted-Average Fair Value Per Option [Member] Measurement input, weighted-average fair value per option. Intangible assets—net Intangible Assets, Net (Excluding Goodwill) Estimated dividend yield Measurement Input, Expected Dividend Rate [Member] $50.40 - $100.20 Price Range Two [Member] Price range two. Product and Service [Domain] Product and Service [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Expected to be exercisable, weighted-average exercise price (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Diluted (loss) income from continuing operations (in USD per shares) Income (Loss) from Continuing Operations, Per Diluted Share Net (loss) income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Liabilities Liabilities, Fair Value Disclosure Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Other Information Cash Flow, Operating Activities, Lessee [Abstract] Development and License Development and License [Member] Development and License City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Number of additional shares available for issuance (in shares) Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Available For Issuance Share based compensation arrangement by share based payment award number of additional shares available for issuance. Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Laboratory equipment Laboratory Equipment [Member] Laboratory equipment. Initial milestone Revenue, Remaining Performance Obligation, Variable Consideration, Clinical Milestone, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Clinical Milestone, Amount Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative Total general and administrative expenses General and Administrative Expense Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Defined contribution plan, Employer matching contribution percentage of match (as percent) Defined Contribution Plan, Employer Matching Contribution, Percent of Match Total Lease Cost Lease, Cost Investments and marketable securities Equity Securities, FV-NI Schedule of Components of Lease Expense Lease, Cost [Table Text Block] Conversion of stock, price, volume weighted average price, number of days Conversion Of Shares, Number Of Days, Volume Weighted Average Price Conversion Of Shares, Number Of Days, Volume Weighted Average Price Assets held for sale Asset, Held-for-Sale, Not Part of Disposal Group, Current Auditor Name Auditor Name iECURE I E C U R E [Member] iECURE member. Warrant liability Warrant Liability Noncurrent Warrant liability noncurrent. Laboratory equipment Equipment [Member] Other Performance Measure, Amount Other Performance Measure, Amount Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Deferred Tax Asset [Domain] Deferred Tax Asset [Domain] Amount Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] (Loss) gain on changes in other fair value adjustments Gain (loss) on changes in fair value of ordinary shares Equity Securities, FV-NI, Gain (Loss) Restricted cash Restricted Cash Amended Plan Amended Plan [Member] Amended Plan member. Other current assets Other Assets, Current Additional paid-in capital Additional Paid in Capital, Common Stock Entity [Domain] Entity [Domain] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Gain from disposal of business Gain on disposal of business Gain (Loss) on Disposition of Business Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Right-of-use assets—net Operating Lease, Right-of-Use Asset Effective tax rate Effective Income Tax Rate Reconciliation, Percent Operating lease cost Operating Lease, Cost Plan Name Plan Name [Domain] Weighted-average period for recognition of compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Stock option exercises (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Less: valuation allowance Deferred Tax Assets, Valuation Allowance Warrant Liability Derivatives, Policy [Policy Text Block] SEGMENT REPORTING Segment Reporting Disclosure [Text Block] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Proceeds from employee stock purchase plan Proceeds From Employee Stock Purchase Plan Proceeds from employee stock purchase plan Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Amortization of discount on note receivable Amortization Of Discount On Note Receivable Amortization of discount on note receivable. Contract liabilities Business Combination, Contingent Consideration, Liability Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Number of additional research programs Number Of Additional Research Programs Number Of Additional Research Programs Amortization of intangible assets Amortization of Intangible Assets Leases Lessee, Leases [Policy Text Block] Laboratory supplies and services Laboratory Supplies And Services Laboratory supplies and services. Total deferred tax assets, noncurrent Deferred Income Tax Assets, Net Purchases of property, equipment and software Payments to Acquire Productive Assets Sale of stock, consideration received Sale of Stock, Consideration Received on Transaction Revolving Credit Facility Revolving Credit Facility [Member] Arrangement Duration Trading Arrangement Duration Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member] Segments [Axis] Segments [Axis] Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] SHARE-BASED COMPENSATION Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Credit Facility Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Debt Instrument Debt Instrument [Axis] Forfeited (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value RETIREMENT PLAN Retirement Benefits [Text Block] Credit Facility Credit Facility [Domain] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Research and development Research and Development [Abstract] Interest rate during period (as a percent) Debt Instrument, Interest Rate, Stated Percentage Investment, Name [Axis] Investment, Name [Axis] Lease liabilities Operating Lease, Liability, Noncurrent Entity Voluntary Filers Entity Voluntary Filers Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] PBGENE-DMD external development costs PBGENE - Duchenne Muscular Dystrophy Program [Member] PBGENE-Duchenne Muscular Dystrophy Program. Proceeds from issuance of common stock to collaboration partners and licensees Stock Issued During Period Value Collaboration Partners And Licenses Stock issued during period value collaboration partners and licenses. Audit Information [Abstract] Audit Information [Abstract] Expected to be exercisable, number of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Assets Assets, Fair Value Disclosure Income Tax Disclosure [Line Items] Income Tax Disclosure [Line Items] Income tax disclosure. RSU grants in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Number of operating segments Number of Operating Segments Accrued research and development expenses Accrued Research And Development Expenses Accrued research and development expenses. Proceeds from repayment of debt Repayments of Convertible Debt Granted (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent [Abstract] Schedule of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Shares outstanding percentage (as percent) Warrants or Rights Outstanding, Ownership Of Common Stock Outstanding, Percentage, Condition For Company Repurchase Warrants or Rights Outstanding, Ownership Of Common Stock Outstanding, Percentage, Condition For Company Repurchase Proceeds from issuance of common stock through ATM facility, net of issuance cost Proceeds from Issuance of Common Stock Through ATM Facility, Net of Issuance Cost Proceeds from issuance of common stock through ATM facility, net of issuance cost Effect of changes in tax laws or rates enacted in the current period Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Name Trading Arrangement, Individual Name Change in warrant liability Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Change In Warrant Liability, Amount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Change In Warrant Liability, Amount Warrants assumptions Warrants and Rights Outstanding, Measurement Input Loan amount Debt Instrument, Face Amount March 2024 Public Offering March 2024 Public Offering [Member] March 2024 Public Offering TG Therapeutics TG Therapeutics [Member] TG Therapeutics [Member] Name Awards Close in Time to MNPI Disclosures, Individual Name Pre-tax book income (loss) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract] Unvested, beginning balance (in USD per shares) Unvested, ending balance (in USD per shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Escrow account cash balance Escrow Deposit Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Defined contribution plan, Employer matching contribution, percent of employees' gross pay (as percent) Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Right of use asset Deferred Tax Liabilities Right Of Use Asset Deferred tax liabilities right of use asset Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Treasury stock Treasury Stock, Value Auditor Firm ID Auditor Firm ID Segments [Domain] Segments [Domain] Income Statement Location Statement of Income Location, Balance [Axis] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Fair Value Hierarchy and NAV Fair Value Hierarchy and NAV [Domain] Investments in equity securities Deferred Tax Liabilities, Investments Assets held for sale Assets Held for Sale [Member] Assets held for sale. Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Net (Loss) Income per Share Earnings Per Share, Policy [Policy Text Block] General and administrative expense General and Administrative Expense [Abstract] Preferred stock: $0.0001 par value— 10,000,000 shares authorized as of December 31, 2025 and December 31, 2024; no shares issued and outstanding as of December 31, 2025 and December 31, 2024 Preferred Stock, Value, Issued All Executive Categories All Executive Categories [Member] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Common stock: $0.000005 par value— 200,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 24,115,346 shares issued and 24,088,425 shares outstanding as of December 31, 2025; 8,229,730 shares issued and 8,202,715 shares outstanding as of December 31, 2024 Common Stock, Value, Issued Employee Share-Based Payment Arrangement, Employee [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Commitments and contingencies (Note 14) Commitments and Contingencies Total number of shares issued under 2019 ESPP (in shares) Numberof Shares Issued Under Employee Stock Purchase Plans Number of shares issued under employee stock purchase plans. Ordinary Shares, Imugene Limited Ordinary Shares [Member] Ordinary shares. Investments in Equity Securities and Investments under the Equity Method Equity Method Investments [Policy Text Block] Ownership percentage in outstanding common stock (as a percent) Equity Method Investment, Ownership Percentage Net deferred tax assets Deferred Tax Assets, Net PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Forfeited/canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Diluted net (loss) income per share: Earnings Per Share, Diluted [Abstract] $50.40 - $100.20 Price Range Seven [Member] Price range seven. Change in fair value of final payment fee Change In Fair Value Of Final Payment Fee Change in the fair value of the final payment fee. All Individuals All Individuals [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Name Forgone Recovery, Individual Name Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Disposal Group Classification Disposal Group Classification [Axis] Reconciliation of cash, cash equivalents and restricted cash: Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Purchase of common stock through payroll deductions expressed in percentage of fair market value (as percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Debt instrument, interest rate increase event of default (as percent) Debt Instrument, Interest Rate Increase Event of Default Debt instrument, interest rate increase event of default. Issuance of warrants Warrants And Rights Issued Warrants and rights issued. Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Tax credits Deferred Tax Assets, Tax Credit Carryforwards Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Proceeds from offering of common stock and warrants through underwritten offering, net of issuance costs Proceeds from Issuance of Common Stock and Warrants Through Underwritten Offering, Net of Issuance Cost Proceeds from issuance of common stock and warrants through underwritten offering, net of issuance cost Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Impairment Charges Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Net (loss) income per share Earnings Per Share [Abstract] Intangible assets amortization expense 2031 and beyond Finite-Lived Intangible Asset, Expected Amortization Expense After Year Five And Thereafter Finite lived intangible assets amortization expense after year five and thereafter. Tax credit carryforwards Tax Credit Carryforward, Amount Deferred revenue Increase (Decrease) in Contract with Customer, Liability Short-Term Debt, Type [Axis] Short-Term Debt, Type [Axis] Investment in equity securities Equity Securities, FV-NI, Noncurrent Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Consideration Received [Domain] Consideration Received [Domain] Consideration Received [Domain] Exercised (in USD per shares) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] 2019 Plan Two Thousand Nineteen Incentive Award Plan [Member] Two thousand nineteen incentive award plan. Additional extension of lease period (in years) Lessee, Operating Lease, Renewal Term Assets held for sale Asset, Held-for-Sale, Not Part of Disposal Group Increase in common stock available for issuance (in shares) Increase In Common Stock Available For Issuance Increase in common stock available for issuance. Less: impairments Intangible Assets, Finite Lived, Accumulated Impairment Loss Intangible Assets, Finite Lived, Accumulated Impairment Loss Net (loss) income Net income (loss) Net Income (Loss) Attributable to Parent Employee-related costs (including share-based compensation) Employee Related Costs Research And Development Including Share-Based Compensation Employee related costs research and development including share-based compensation. Construction in progress Construction in Progress [Member] Basic gain (loss) from discontinued operations (in USD per shares) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Schedule of Reconciliation of Federal Statutory Income Tax Rate and Income Tax Benefit Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Expected term (in years) Measurement Input, Expected Term [Member] $122.40 - $174.90 Price Range Three [Member] Price range three. Customer [Axis] Customer [Axis] Operating loss Operating loss Operating Income (Loss) Line of Credit Line of Credit [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Schedule of Stock-Based Compensation Expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Defined contribution plan, maximum annual contributions per employee (as percent) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Current liabilities of discontinued operations Total current liabilities of discontinued operations Disposal Group, Including Discontinued Operation, Liabilities, Current Statement [Table] Statement [Table] Total other income Other Nonoperating Income (Expense) Adjustments to reconcile net (loss) income to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Revenue Benchmark Revenue Benchmark [Member] Weighted-average risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Shares received on mature of convertible note (in shares) Shares, Issued Collaborative arrangement, upfront payments and liabilities Contract with Customer, Liability (Gain) loss on disposal of assets Gain (Loss) on Disposition of Assets for Financial Service Operations Summary of Financial Assets Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Sale of stock, price per share (in USD per shares) Sale of Stock, Price Per Share Maximum shares allowed to be issued under ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized CMOs and outsourced research and development CMOs And Outsourced Research And Development CMOs and outsourced research and development. Termination Date Trading Arrangement Termination Date Contract asset Increase (Decrease) in Contract with Customer, Asset Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Receivable [Domain] Receivable [Domain] Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Summary of Activity of Option Plans Share-Based Payment Arrangement, Option, Activity [Table Text Block] Percentage of value of each additional milestone payment (as percent) Percentage Of Value Of Each Additional Milestone Payment Percentage of value of each additional milestone payment. Unrecognized tax benefits, income tax penalties and interest accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Basic (in shares) Basic weighted-average common shares (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Fair value of warrants Balance at December 31, 2024 Balance at December 31, 2025 Warrants and Rights Outstanding Schedule of Basic and Diluted Net (Loss) Income Per Share Attributable to Common Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Currently exercisable, number of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Discovery and Development Discovery and Development [Member] Discovery and Development Exercise Price Range Exercise Price Range [Domain] Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Segment Reporting [Abstract] Weighted-average fair value per option (in USD per shares) Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Fair Value Per Option Share based compensation arrangement by share based payment award fair value assumptions weighted average fair value per option. Debt Disclosure [Abstract] Debt Disclosure [Abstract] Shares available for exchange (in shares) Collaborative Arrangement, Shares Available For Exchange Collaborative Arrangement, Shares Available For Exchange Nonemployee Share-Based Payment Arrangement, Nonemployee [Member] Issuance of common stock in exchange for services Issuance of Stock and Warrants for Services or Claims Unamortized revolving line debt discount balance Debt Instrument, Unamortized Discount Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in USD per shares) Common Stock, Par or Stated Value Per Share Notes received Receivable with Imputed Interest, Face Amount Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Use of Estimates Use of Estimates, Policy [Policy Text Block] Contract asset Contract Asset Current Contract asset current. Guarantor Obligations, Nature [Axis] Guarantor Obligations, Nature [Axis] Write-offs Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements $122.40 - $174.90 Price Range Eight [Member] Price range eight. Number of options outstanding (in shares) Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding SUBSEQUENT EVENTS Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Investment in iECURE Equity Securities [Member] Provision to return Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent Total liabilities Liabilities Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Proceeds from issuance of common stock, net of issuance cost Stock Issued During Period, Value, New Issues Payment Tranche One Payment Tranche One [Member] Payment Tranche One Counterparty Name Counterparty Name [Axis] Summary of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Tax Credit Carryforward, Name Tax Credit Carryforward, Name [Domain] Fair value of non-option, grants in period Share Based Compensation Arrangement By Share Based Payment Award, Non Option Equity Instruments, Grant Date Fair Value Share based compensation arrangement by share based payment award non-options grant date fair value. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Gain on change in fair value of warrant liability Gain on change in fair value of warrant liability Gain on change in fair value of warrant liability. Non-NEOs Non-NEOs [Member] $305.10 - $480.00 Price Range Ten [Member] Price range ten. Useful Life, Lease Term [Member]